Nuttall F Q, Gannon M C
Section of Endocrinology, Metabolism and Nutrition, Veterans Administration Medical Center, Minneapolis, Minnesota 55417.
J Biol Chem. 1993 Jun 25;268(18):13286-90.
Glycogen synthase catalyzes the transfer of the glucosyl moiety from UDP-glucose to the terminal branch of the glycogen molecule and is considered to be the rate-limiting enzyme for glycogen synthesis. However, under ideal assay conditions, i.e. 37 degrees C with saturating concentrations of UDP-glucose and the activator, glucose-6-P, the maximal catalytic activity of glycogen synthase was only 78% of the in vivo glycogen synthetic rate. Using concentrations of UDP-glucose and glucose-6-P likely to be present in vivo, the rate was only approximately 30%. This prompted us to reassess a possible role of allosteric effectors on synthase activity. Glycogen synthase was assayed at 37 degrees C using dilute, pH 7.0, buffered extracts, initial rate conditions, and UDP-glucose and glucose-6-P concentrations, which approximate those calculated to be present in total liver cell water. Several allosteric effectors were tested. Magnesium and AMP had little effect on activity. Pi, ADP, ATP, and UTP inhibited activity. When a combination of effectors were added at concentrations approximating those present in cell water, synthase activity could account for only 2% of the glycogen synthetic rate. Thus, although allosteric effectors are likely to be playing a major role in regulating synthase enzymic activity in liver cells, to date, a metabolite that can stimulate activity and/or overcome nucleotide inhibition has yet to be identified. If such a metabolite cannot be identified, an additional or alternative pathway for glycogen synthesis must be considered.
糖原合酶催化将UDP - 葡萄糖的葡萄糖基部分转移至糖原分子的末端分支,被认为是糖原合成的限速酶。然而,在理想的测定条件下,即37℃、UDP - 葡萄糖和激活剂葡萄糖 - 6 - 磷酸浓度饱和时,糖原合酶的最大催化活性仅为体内糖原合成速率的78%。使用体内可能存在的UDP - 葡萄糖和葡萄糖 - 6 - 磷酸浓度时,该速率仅约为30%。这促使我们重新评估变构效应剂对合酶活性的可能作用。在37℃下,使用稀释的、pH 7.0的缓冲提取物、初始速率条件以及近似计算得出的存在于全肝细胞水中的UDP - 葡萄糖和葡萄糖 - 6 - 磷酸浓度来测定糖原合酶。测试了几种变构效应剂。镁和AMP对活性影响很小。磷酸、ADP、ATP和UTP抑制活性。当以近似细胞水中存在的浓度添加效应剂组合时,合酶活性仅占糖原合成速率的2%。因此,尽管变构效应剂可能在调节肝细胞中的合酶酶活性方面发挥主要作用,但迄今为止,尚未鉴定出能够刺激活性和/或克服核苷酸抑制作用的代谢物。如果无法鉴定出这样的代谢物,则必须考虑糖原合成的额外或替代途径。